Impact of special patient populations on the pharmacokinetics of echinocandins
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of special patient populations on the pharmacokinetics of echinocandins
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 13, Issue 6, Pages 799-815
Publisher
Informa UK Limited
Online
2015-05-07
DOI
10.1586/14787210.2015.1028366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Disposition in Obesity: Toward Evidence-Based Dosing
- (2015) Catherijne A.J. Knibbe et al. Annual Review of Pharmacology and Toxicology
- Pharmacokinetic and Safety Profiles of Repeated-dose Prophylactic Micafungin in Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation
- (2015) Edythe Albano et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- In silico-derived bedside formula for individualized micafungin dosing for obese patients in the age of deterministic chaos
- (2015) JP Pasipanodya et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis
- (2014) Ping Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications
- (2014) Chris Stockmann et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and Pharmacodynamics of Antifungals in Children: Clinical Implications
- (2014) Julie Autmizguine et al. DRUGS
- Pharmacokinetic profile of micafungin when co-administered with amphotericin B in healthy male subjects
- (2014) Nasrullah A. Undre et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration
- (2014) Emilio Maseda et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration
- (2014) Gerardo Aguilar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of caspofungin in ICU patients
- (2014) E. W. Muilwijk et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
- (2014) Andreas H Groll et al. LANCET ONCOLOGY
- Epidemiology and risk factors for invasive candidiasis
- (2014) Nur Yapar Therapeutics and Clinical Risk Management
- Favorable Outcome of Neonatal Cerebrospinal Fluid Shunt-Associated Candida Meningitis with Caspofungin
- (2013) Jop Jans et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Escalating Doses of Caspofungin in a Phase II Study of Patients with Invasive Aspergillosis
- (2013) Gudrun Würthwein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low but Sufficient Anidulafungin Exposure in Critically Ill Patients
- (2013) Marjolijn J. P. van Wanrooy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Weight Drives Caspofungin Pharmacokinetic Variability in Overweight and Obese People: Fractal Power Signatures beyond Two-Thirds or Three-Fourths
- (2013) Ronald G. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Caspofungin in Critically Ill Patients on Continuous Renal Replacement Therapy
- (2013) Stefan Weiler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis
- (2013) Ping Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling
- (2013) Rick Admiraal et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations
- (2013) Ibrahim Ince et al. CLINICAL PHARMACOKINETICS
- Neonatal sepsis: Progress towards improved outcomes
- (2013) Andi L. Shane et al. JOURNAL OF INFECTION
- Safety and Pharmacokinetic Profiles of Repeated-dose Micafungin in Children and Adolescents Treated for Invasive Candidiasis
- (2013) Daniel K. Benjamin et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation
- (2013) K. Oshima et al. Transplant Infectious Disease
- Pharmacokinetics of Caspofungin in Two Patients with Burn Injuries
- (2012) V. Jullien et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic-Pharmacodynamic Analysis of Anidulafungin in Adult Patients with Fungal Infections
- (2012) Ping Liu ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
- (2012) D. R. Andes et al. CLINICAL INFECTIOUS DISEASES
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
- (2012) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *Information in this manuscript was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases
- (2012) A.J. Ullmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
- (2012) W.W. Hope et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
- (2012) Margreke J.E. Brill et al. CLINICAL PHARMACOKINETICS
- Improving antibiotic dosing in special situations in the ICU
- (2012) Janattul-Ain Jamal et al. Current Opinion in Critical Care
- Drug interactions between micafungin at high doses and cyclosporine A in febrile neutropenia patients after allogeneic hematopoietic stem cell transplantation
- (2012) Yasuyuki Inoue et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetics of Micafungin in Pediatric Patients With Invasive Candidiasis and Candidemia
- (2012) Nasrullah A. Undre et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Impact of a Transjugular Intrahepatic Portosystemic Shunt on the Pharmacokinetics of Caspofungin in a Critically Ill Patient
- (2012) Isabel Spriet et al. PHARMACOLOGY
- Plasma concentrations of caspofungin at two different dosage regimens in a patient with hepatic dysfunction
- (2012) K.C.M. van der Elst et al. Transplant Infectious Disease
- Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients
- (2011) Chi-Chung Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetics of Liposomal Amphotericin B and Caspofungin in Allogeneic Hematopoietic Stem Cell Recipients
- (2011) Gudrun Würthwein et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fractal Geometry and the Pharmacometrics of Micafungin in Overweight, Obese, and Extremely Obese People
- (2011) Ronald G. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
- (2011) O. A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Micafungin Concentrations in the Plasma and Burn Eschar of Severely Burned Patients
- (2011) Junichi Sasaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia
- (2011) David Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding
- (2011) Souzan B. Yanni et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates
- (2011) M Cohen-Wolkowiez et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Implications of Obesity for Drug Therapy: Limitations and Challenges
- (2011) R Jain et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis
- (2011) Isabel Spriet et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Micafungin therapy in a critically ill, morbidly obese patient
- (2011) A. Zomp et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration
- (2011) J. M. Leitner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modeling and predicting drug pharmacokinetics in patients with renal impairment
- (2011) Karen Rowland Yeo et al. Expert Review of Clinical Pharmacology
- Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients
- (2010) A. H. Groll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
- (2010) D. Andes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
- (2010) J Maertens et al. BONE MARROW TRANSPLANTATION
- The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients
- (2010) Marta Ulldemolins et al. CLINICAL PHARMACOKINETICS
- Echinocandin Antifungal Drugs in Fungal Infections
- (2010) Sharon C.-A. Chen et al. DRUGS
- Safety and Pharmacokinetics of Higher Doses of Caspofungin in Healthy Adult Participants
- (2010) Elizabeth M. Migoya et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Lack of Pharmacokinetic Drug Interaction Between Oral Posaconazole and Caspofungin or Micafungin
- (2010) Gopal Krishna et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Micafungin Does Not Influence the Concentration of Tacrolimus in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) N. Fukuoka et al. TRANSPLANTATION PROCEEDINGS
- The Impact of Total Bilirubin on Plasma Micafungin Levels in Living-Donor Liver Transplantation Recipients with Severe Liver Dysfunction
- (2009) Yuichi Muraki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
- (2009) Roger J. M. Brüggemann et al. CLINICAL INFECTIOUS DISEASES
- A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
- (2009) Robert F. Betts et al. CLINICAL INFECTIOUS DISEASES
- Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants
- (2009) D K Benjamin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Extended daily dialysis does not affect the pharmacokinetics of anidulafungin
- (2009) Olaf Burkhardt et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation
- (2009) I. Spriet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- PHARMACOKINETICS OF PROPHYLACTIC MICAFUNGIN IN VERY-LOW-BIRTH-WEIGHT INFANTS
- (2009) Mayumi Kawada et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pharmacokinetics of an Elevated Dosage of Micafungin in Premature Neonates
- (2009) P Brian Smith et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers
- (2008) M. Neely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of Caspofungin in Neonates and Infants Less than 3 Months of Age
- (2008) X. Saez-Llorens et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of Burns on Pharmacokinetics and Pharmacodynamics of Drugs Used in the Care of Burn Patients
- (2008) Benoit Blanchet et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
- (2008) Roger K. Verbeeck EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation
- (2008) Stéphanie Ruiz et al. INTENSIVE CARE MEDICINE
- Caspofungin as First-Line Therapy for the Treatment of Invasive Aspergillosis After Thoracic Organ Transplantation
- (2008) Jan Groetzner et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Population pharmacokinetics of micafungin in adult patients
- (2007) Tawanda Gumbo et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental HematogenousCandidaMeningoencephalitis: Implications for Echinocandin Therapy in Neonates
- (2007) William W. Hope et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now